Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vyome Holdings, IncOBLN · Entity 1824 | Chief Clinical & Reg Officer | January 24, 2020 | January 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vyome Holdings, Inc
Report date January 24, 2020 · Filed January 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 88,225 |
Reported balance
After 2020-01-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-24 · Grant · Acquired 88,225 · Balance 88,225 F1: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 24, 2020 Filed Jan 28, 2020 16:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantRestricted Stock Units · Derivative | 88,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-000641 · marketforms-47575.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,225 Underlying: Common Stock · 88,225 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 16:40 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001214659-19-006669 · marketforms-45996.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-10-25 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 16:40 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001214659-19-006668 · marketforms-45996.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-10-25 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 14:26 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseWarrants (Right to Buy) · Derivative | 1,875 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001214659-19-005087 · marketforms-45432.xml · derivative · entry 2 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires 2024-08-06 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 14:26 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 2,500 | $4.00 | $10,000.00 |
DisclosureSEC source: 0001214659-19-005087 · marketforms-45432.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,764 F1 · price: Reflects price paid to underwriters in Issuer's registered offering. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001214659-19-004754 · marketforms-45368.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-07-23 F1 · derivative.exercise_date: Subject to the grantee's continued status as a service provider with the Issuer through the applicable vesting date, the option shall vest as to 100% of the shares underlying the option on the day following the filing date of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, based on the achievement of performance goals on or prior to December 31, 2019. F2 · derivative.underlying_shares: Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:31 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001214659-19-000151 · marketforms-43643.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · Chief Clinical & Reg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:33 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock | 10,989 | $1.82 | $19,999.98 |
DisclosureSEC source: 0001214659-18-005738 · marketforms-42788.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,639 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| May 15, 2018 Filed May 17, 2018 19:19 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock (Restricted Stock Award) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003873 · marketforms-42032.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,541 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 6 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,541 shares Expires 2021-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,087 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 5 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,087 shares Expires 2020-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,022 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · derivative · entry 4 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,022 shares Expires 2018-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionCommon Stock | 1,541 | $1.31 | $2,018.71 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 3 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionCommon Stock | 1,087 | $0.87 | $945.69 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 2 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 18:47 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | Exercise / conversionCommon Stock | 4,022 | $0.87 | $3,499.14 |
DisclosureSEC source: 0001214659-18-000757 · marketforms-40861.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:09 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock (Restricted Stock Award) | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-000184 · marketforms-40651.xml · nonDerivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · shares: The Restricted Shares shall vest as to one-fourth of the Shares underlying the Award on each of the first, second, third and fourth anniversaries of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 17:44 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.74 | $0.00 |
DisclosureSEC source: 0001209191-16-149830 · doc4.xml · derivative · entry 1 VandenBerg Amy · CIK 0001685638 · VP of Reg. and Clin. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, commencing on December 9, 2016, with 100% of the total shares vested on November 9, 2020, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.